Skip to main content
TipRanks
Go Ultimate75% OFF

Arcutis Biotherapeutics (ARQT) Hedge Fund Trading Activity

993 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 3.0M Shares Last Quarter

Hedge Fund Holdings in ARQT

4.00M$7.008.00M$13.8812.00M$20.7516.00M$27.6320.00M$34.50Jul '24Jan '25Jul '25Jan '26Jul '26$28.38Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
Kenneth Tropin hedge funds manager, Graham Capital Management, L.P.,Rank 67Kenneth TropinGraham Capital Management, L.P.New100.00%$262,777<0.01%
BlackRock, Inc. hedge funds manager,  ,Rank 343BlackRock, Inc. Added14.62%$276,502,119<0.01%
Michael Rockefeller hedge funds manager, Woodline Partners LP,Rank 460Michael RockefellerWoodline Partners LPNot Changed0.00%$5,113,7650.02%
Steve Weber hedge funds manager, Driehaus Capital Management LLC,Rank 54Steve WeberDriehaus Capital Management LLCReduced-60.54%$23,032,3300.13%
Travis Knapp Anderson hedge funds manager, Gilder Gagnon Howe & Co LLC.,Rank 123Travis Knapp AndersonGilder Gagnon Howe & Co LLC.Reduced-69.49%$34,432,3920.36%
Andrew J.M. Spokes hedge funds manager, Farallon Capital Management, L.L.C.,Rank 2Andrew J.M. SpokesFarallon Capital Management, L.L.C.Sold Out-100.00%$00.00%
Scott Jarred hedge funds manager, Invst, LLC,Rank 254Scott JarredInvst, LLCSold Out-100.00%$00.00%

FAQ

Which hedge funds hold Arcutis Biotherapeutics?
The hedge funds that hold the most shares in Arcutis Biotherapeutics are Scott Jarred, Steve Weber and BlackRock, Inc..
Are hedge funds buying or selling ARQT?
In the last quarter hedge funds have Decreased their holdings in Arcutis Biotherapeutics by 3.0M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Arcutis Biotherapeutics stock?
Warren Buffet currently does not own shares in Arcutis Biotherapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here